Promega
Promega celebrates scientific discovery and the creative application of science to solve problems. It develops high-quality tools life scientists use to seek answers.
Latest Promega Content
Video
Advertisement
Teach Me in 10 – Engineering RNA for Therapeutic Success
In this Teach Me in 10 episode, product specialist Leah Cronan explores the growing impact of RNA therapeutics. She highlights how transitioning to cell-free production methods results in consistent, scalable RNA production with fewer bottlenecks.
Product News
Promega Engineers New Enzyme To Significantly Reduce Stutter in Forensic DNA Analysis
A novel enzyme developed by research scientists at Promega Corporation will virtually eliminate confounding stutter artifacts in forensic DNA analysis.
App Note / Case Study
How To Transition From Liquid to Lyophilized PCR Assays
This application note details how to transition liquid PCR assays to lyophilized formats, summarizing the technical procedure and benefits of lyophilized assays.
Product News
Promega UK Announces Winners of the 2023 Helix Sustainability Awards
The Life Sciences Company based on the University of Southampton Science Park in Hampshire, has announced the winners of this year’s Helix Sustainability Awards.
Product News
Promega Launches Portable 96-Well Plate Reader To Analyze Luminescent Cell Health Assays
Researchers can detect luminescent signals using small, inexpensive MyGlo™ Reagent
Reader.
Reader.
Product News
Promega Kit Enables European Forensic Labs To Solve Challenging Cold Cases
Eight-color kit provides more usable information from degraded or inhibited DNA samples. Includes all DNA markers recommended by the European Network of Forensic Science Institutes (ENFSI).
Product News
Promega Maxwell® DE System Accelerates Sexual Assault Kit Processing with Automated Protocol
Maxwell DE System is the first automated differential extraction kit eliminating the need for DNA purification following cell separation.
News
Protein Degrader Technology May Reduce Drug Development Failure Rate
Researchers have used protein degrader technology to show whether potential drug treatments are worth progressing into human trials, in a game-changing move that is already being used to establish drug targets for hard-to-treat cancers.
Advertisement